Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$39.95 USD
-0.20 (-0.50%)
Updated Dec 8, 2023 04:00 PM ET
After-Market: $39.93 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/20/2024
Time: -- |
12/2023 | $0.78 | 1.94% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.71 per share. This reflects a positive earnings surprise of 5.63%. Look out for HALO's next earnings release expected on February 20, 2024. For the next earning release, we expect the company to report earnings of $0.78 per share, reflecting a year-over-year increase of 62.5%.
Earnings History
Price & Consensus
Zacks News for HALO
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services